Scott Bertch

Executive Director, Clinical Site Head • Tenaya Therapeutics

Scott Bertch is currently Executive Director, Clinical Site Head at Tenaya Therapeutics, a company with a mission to discover, develop, and deliver curative therapies that target the underlying causes of heart disease. Scott has 25 years of experience in the pharmaceutical and biotechnology field specializing in the design, construction, automation and validation of production facilities. Scott has developed and maintained programs for engineering project delivery, equipment acquisition, and commissioning & qualification. Prior to Joining Tenaya, Scott served as Senior Director of Technical Operations at Novartis Gene Therapies where he executed major capital projects to design and construct manufacturing, laboratories, warehousing and office complexes for cutting-edge gene therapy manufacturing technologies and modular facility design. Scott’s areas of expertise include applying engineering, validation, and automated solutions to complex processes in the bio tech and gene therapy space.

Also Speaking

Jeff Liter

President and Chief Executive Officer • Luminary Therapeutics

Emily McGinnis

Chief Patient Officer • Taysha Gene Therapies

David Sheehan

President & Chief Executive Officer • Nucleus Biologics

Also Speaking


Germfree Truck



Book your hotel room for your stay in Miami.